The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKerry Regulatory News (KYGA)

Share Price Information for Kerry (KYGA)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 80.40
Bid: 80.00
Ask: 81.50
Change: -2.30 (-2.78%)
Spread: 1.50 (1.875%)
Open: 80.40
High: 80.60
Low: 79.20
Prev. Close: 82.70
KYGA Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Kerry Increases its Stake in Proparent B.V.

7 Oct 2022 07:00

RNS Number : 0863C
Kerry Group PLC
07 October 2022
 

 

 

7 October 2022

LEI: 635400TLVVBNXLFHWC59

 

KERRY GROUP

Kerry Increases its Stake in Proparent B.V. (Owner of Ojah B.V.)

Kerry Group plc ("Kerry"), the global taste & nutrition company, today announces that it has reached agreement to increase its joint venture stake in Proparent B.V. ("Proparent"), which is the 100% owner of Ojah B.V. ("Ojah") - the Dutch manufacturer of texturised plant-based proteins. Having initially purchased a 55% stake in 2018, Kerry will increase its holding to 75% for an incremental consideration of €20m in line with terms agreed at the time of the initial investment. Thomas Ahlinder, President & CEO Kerry Europe commented "The partnership with Ojah has delivered excellent growth thanks to its high-quality offering. Kerry has unique expertise in addressing the multitude of complexities in delivering taste, nutrition, and functionality combined with sustainable plant protein substrates, thereby supporting our customers in providing differentiated solutions that address the needs of a dynamic consumer base".

Acquisitions are an important part of Kerry's strategy. In order to give further insight and context for its acquisitions, Kerry is providing additional information in relation to the acquisitions that it completes including, stating for each acquisition whether equity or assets were acquired and the strategic rationale for the acquisition. Included also is the percentage of voting equity acquired in the case of an equity acquisition, and the business unit/line acquired in the case of an asset acquisition. A table setting out this information in relation to the acquisitions made by Kerry in the period 2011 to 2022 year to date is available on Kerry's website under the financial highlights section on kerry.com/investors.

 

 

ENDS

 

 

CONTACT INFORMATION

 

Investor Relations

Marguerite Larkin, Chief Financial Officer

+353 66 7182292 | investorrelations@kerry.ie

 

 

William Lynch, Head of Investor Relations

+353 66 7182292 | investorrelations@kerry.ie

 

Media

 

Catherine Keogh, Chief Corporate Affairs & Brand Officer

 

+353 45 930188 | corpaffairs@kerry.com

Website

 

www.kerry.com

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
JVEUPGGWUUPPGQQ
Date   Source Headline
3rd May 202412:10 pmRNSKerry Announces €300m Share Buyback Programme
2nd May 20244:14 pmRNSResult of AGM
2nd May 20247:00 amRNSQ1 Interim Management Statement 2024
1st May 202410:05 amRNSTotal Voting Rights
30th Apr 20247:00 amRNSTransaction in Own Shares
29th Apr 20247:00 amRNSTransaction in Own Shares
26th Apr 20247:00 amRNSTransaction in Own Shares
25th Apr 20247:00 amRNSTransaction in Own Shares
24th Apr 20247:00 amRNSTransaction in Own Shares
23rd Apr 20247:00 amRNSTransaction in Own Shares
22nd Apr 20247:00 amRNSTransaction in Own Shares
19th Apr 20247:00 amRNSTransaction in Own Shares
18th Apr 20247:00 amRNSTransaction in Own Shares
17th Apr 20247:00 amRNSTransaction in Own Shares
16th Apr 202412:42 pmRNSHolding(s) in Company
16th Apr 20247:00 amRNSTransaction in Own Shares
15th Apr 20247:00 amRNSTransaction in Own Shares
12th Apr 20247:00 amRNSTransaction in Own Shares
11th Apr 20247:00 amRNSTransaction in Own Shares
10th Apr 20247:00 amRNSTransaction in Own Shares
9th Apr 20247:00 amRNSTransaction in Own Shares
8th Apr 20247:00 amRNSTransaction in Own Shares
5th Apr 20247:00 amRNSTransaction in Own Shares
4th Apr 20247:00 amRNSTransaction in Own Shares
3rd Apr 20247:00 amRNSTransaction in Own Shares
2nd Apr 20249:48 amRNSTotal Voting Rights
2nd Apr 20247:00 amRNSTransaction in Own Shares
28th Mar 202411:55 amRNSNotice of AGM
28th Mar 20247:00 amRNSTransaction in Own Shares
27th Mar 20247:00 amRNSTransaction in Own Shares
26th Mar 20247:00 amRNSTransaction in Own Shares
25th Mar 20247:00 amRNSTransaction in Own Shares
22nd Mar 20247:00 amRNSTransaction in Own Shares
21st Mar 20247:00 amRNSTransaction in Own Shares
19th Mar 20247:00 amRNSTransaction in Own Shares
18th Mar 20247:00 amRNSTransaction in Own Shares
15th Mar 202410:30 amRNSAnnual Financial Report
15th Mar 20247:00 amRNSTransaction in Own Shares
14th Mar 20247:00 amRNSTransaction in Own Shares
13th Mar 20247:00 amRNSTransaction in Own Shares
12th Mar 20247:00 amRNSTransaction in Own Shares
11th Mar 20247:00 amRNSTransaction in Own Shares
8th Mar 20247:00 amRNSTransaction in Own Shares
7th Mar 202412:42 pmRNSDirector/PDMR Shareholding
7th Mar 202412:39 pmRNSDirector/PDMR Shareholding
7th Mar 202412:34 pmRNSDirector/PDMR Shareholding
7th Mar 20247:00 amRNSTransaction in Own Shares
6th Mar 20247:00 amRNSTransaction in Own Shares
5th Mar 20247:00 amRNSTransaction in Own Shares
4th Mar 20247:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.